443 related articles for article (PubMed ID: 30248193)
21. Orodispersible drug formulations for children and elderly.
Slavkova M; Breitkreutz J
Eur J Pharm Sci; 2015 Jul; 75():2-9. PubMed ID: 25736528
[TBL] [Abstract][Full Text] [Related]
22. Acceptability of an orodispersible film compared to syrup in neonates and infants: A randomized controlled trial.
Klingmann V; Pohly CE; Meissner T; Mayatepek E; Möltner A; Flunkert K; Breitkreutz J; Bosse HM
Eur J Pharm Biopharm; 2020 Jun; 151():239-245. PubMed ID: 32348882
[TBL] [Abstract][Full Text] [Related]
23. Paediatric and geriatric drug delivery.
Breitkreutz J; Boos J
Expert Opin Drug Deliv; 2007 Jan; 4(1):37-45. PubMed ID: 17184161
[TBL] [Abstract][Full Text] [Related]
24. European perspectives on pediatric formulations.
Breitkreutz J
Clin Ther; 2008 Nov; 30(11):2146-54. PubMed ID: 19108802
[TBL] [Abstract][Full Text] [Related]
25. Pediatric drug development: formulation considerations.
Ali AA; Charoo NA; Abdallah DB
Drug Dev Ind Pharm; 2014 Oct; 40(10):1283-99. PubMed ID: 24483293
[TBL] [Abstract][Full Text] [Related]
26. Orally disintegrating films and mini-tablets-innovative dosage forms of choice for pediatric use.
Preis M
AAPS PharmSciTech; 2015 Apr; 16(2):234-41. PubMed ID: 25739913
[TBL] [Abstract][Full Text] [Related]
27. Formulation of medicines for children.
Nunn T; Williams J
Br J Clin Pharmacol; 2005 Jun; 59(6):674-6. PubMed ID: 15948931
[TBL] [Abstract][Full Text] [Related]
28. Development of Oral Flexible Tablet (OFT) Formulation for Pediatric and Geriatric Patients: a Novel Age-Appropriate Formulation Platform.
Chandrasekaran P; Kandasamy R
AAPS PharmSciTech; 2017 Aug; 18(6):1972-1986. PubMed ID: 27921260
[TBL] [Abstract][Full Text] [Related]
29. A review on taste masked multiparticulate dosage forms for paediatric.
Al-Japairai K; Hamed Almurisi S; Almonem Doolaanea A; Mahmood S; Alheibshy F; Alobaida A; Abdul-Halim N; Chatterjee B
Int J Pharm; 2023 Feb; 632():122571. PubMed ID: 36587776
[TBL] [Abstract][Full Text] [Related]
30. Eunice Kennedy Shriver National Institute of Child Health and Human Development Pediatric Formulation Initiative: selected reports from working groups.
Giacoia GP; Taylor-Zapata P; Mattison D
Clin Ther; 2008 Nov; 30(11):2097-101. PubMed ID: 19108797
[TBL] [Abstract][Full Text] [Related]
31. Pediatric drugs--a review of commercially available oral formulations.
Strickley RG; Iwata Q; Wu S; Dahl TC
J Pharm Sci; 2008 May; 97(5):1731-74. PubMed ID: 17823956
[TBL] [Abstract][Full Text] [Related]
32. Acceptability of Mini-Tablets in Young Children: Results from Three Prospective Cross-over Studies.
Klingmann V
AAPS PharmSciTech; 2017 Feb; 18(2):263-266. PubMed ID: 27714698
[TBL] [Abstract][Full Text] [Related]
33. Pediatric Oral Formulations: An Updated Review of Commercially Available Pediatric Oral Formulations Since 2007.
Strickley RG
J Pharm Sci; 2019 Apr; 108(4):1335-1365. PubMed ID: 30447227
[TBL] [Abstract][Full Text] [Related]
34. Overview of drug product development.
Narayan P
Curr Protoc Pharmacol; 2011 Dec; Chapter 7():Unit 7.3.1-29. PubMed ID: 22147349
[TBL] [Abstract][Full Text] [Related]
35. Evidence of acceptability of oral paediatric medicines: a review.
Mistry P; Batchelor H;
J Pharm Pharmacol; 2017 Apr; 69(4):361-376. PubMed ID: 27524471
[TBL] [Abstract][Full Text] [Related]
36. Acceptability of multiple coated mini-tablets in comparison to syrup in infants and toddlers: a randomised controlled study.
Klingmann V; Hinder M; Langenickel TH; Chen F; Khder Y; Breitkreutz J; Bosse HM
Arch Dis Child; 2023 Sep; 108(9):730-735. PubMed ID: 36963813
[TBL] [Abstract][Full Text] [Related]
37. Patient centric formulations for paediatrics and geriatrics: Similarities and differences.
Hanning SM; Lopez FL; Wong IC; Ernest TB; Tuleu C; Orlu Gul M
Int J Pharm; 2016 Oct; 512(2):355-359. PubMed ID: 26976504
[TBL] [Abstract][Full Text] [Related]
38. Effects of the pharmaceutical technologic aspects of oral pediatric drugs on patient-related outcomes: a systematic literature review.
van Riet-Nales DA; Schobben AF; Egberts TC; Rademaker CM
Clin Ther; 2010 May; 32(5):924-38. PubMed ID: 20685501
[TBL] [Abstract][Full Text] [Related]
39. Practical approaches of taste masking technologies in oral solid forms.
Douroumis D
Expert Opin Drug Deliv; 2007 Jul; 4(4):417-26. PubMed ID: 17683254
[TBL] [Abstract][Full Text] [Related]
40. Acceptability of Multiple Uncoated Minitablets in Infants and Toddlers: A Randomized Controlled Trial.
Klingmann V; Linderskamp H; Meissner T; Mayatepek E; Moeltner A; Breitkreutz J; Bosse HM
J Pediatr; 2018 Oct; 201():202-207.e1. PubMed ID: 29960767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
